1. Anderson, T.F. and Voorhees, J.J., 1980, Psoralen photochemotherapy of cutaneous disorders, Ann. Rev. Pharmacol. Toxicol., 20: 235–257.
2. Averbeck, D., Dubertret, L., Bisagni, E. and Moron, J., 1982, Towards more safety in PUVA-therapy with new monofunctional psoralens, Int. Workshops on Investigative Dermatology, Kyoto, May 31-June 1, Abstr. W2–18.
3. Averbeck, D., Dubertret, L., Bisagni, E., Moron, J., Papadopoulo, D., Nocentini, S., Blais, J. and Zajdela, F., 1983, Photobiological and phototherapeutic properties of new monofunctional pyridopsoralens, J. Invest. Dermatol. 80: 306.
4. Averbeck, D., 1984, Photochemistry and photobiology of psoralens, Proc. Jpn. Soc. Invest. Dermatol., 8: 52–73.
5. Averbeck, D., Averbeck, S., Bisagni, E. and Moron, J., 1985 Lethal and mutagenic effects photoinduced in haploid yeast (Saccaromyces cerevisiae) by two monofunctional pyridopsoralens compared to 3-carbethoxypsoralen and 8methoxypsoralen. Mutation Res., 148:47–57.